VIJAYA CHALLA: Open Payments
NPI 1528016490 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 25 payments from 8 companies in 2025. Trend: 2023 $129 · 2024 $367 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $207 |
| GlaxoSmithKline, LLC. | 5 | $105 |
| PFIZER INC. | 3 | $56 |
| Exact Sciences Corporation | 2 | $36 |
| Novo Nordisk Inc | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| Braeburn Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, Cologuard Collection Kit, ELIQUIS, AIRSUPRA, Ozempic, PAXLOVID, TZIELD, BREZTRI.
Industry payments across MI — which companies pay providers there.
